Clinical Trials Browser

Phase 1 × Solid Tumors × Sunitinib × Clear all

NCT02058901 2019-07-17

Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00720148 2014-08-26

A Phase I Trial of Bortezomib and Sunitinib

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00495872 2012-10-18

Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumors